Transgenic mice that overexpress PKCA in the epidermis (K5-PKCA mice) exhibit acute CXCR2-mediated intraepidermal neutrophilic inflammation and a strong epidermal hyperplasia in response to application of 12-O-tetradecanoylphorbol-13-acetate (TPA). We now show that hyperplasia is independent of infiltrating neutrophils. Furthermore, when K5-PKCA mice were initiated with 7,12-dimethylbenz(a)annthracene (DMBA) and promoted with a low dose of TPA, 58% of K5-PKCA mice developed skin papillomas that progressed to carcinoma, whereas wild-type mice did not develop tumors. We confirmed that CXCR2 is expressed by keratinocytes and showed that transformation by oncogenic ras (a hallmark of DMBA initiation) or TPA exposure induced all CXCR2 ligands. Ras induction of CXCR2 ligands was mediated by autocrine activation of epidermal growth factor receptor and nuclear factor-KB, and potentiated by PKCA. Oncogenic ras also induced CXCR2 ligands in keratinocytes genetically ablated for CXCR2. However, ras transformed CXCR2 null keratinocytes formed only small skin tumors in orthotopic skin grafts to CXCR2 intact hosts, whereas transformed wild-type keratinocytes produced large tumors. In vitro, CXCR2 was essential for CXCR2 ligand-stimulated migration of ras-transformed keratinocytes and for ligand activation of the extracellular signal-regulated kinase (ERK) and Akt pathways. Both migration and activation of ERK and Akt were restored by CXCR2 reconstitution of CXCR2 null keratinocytes. Thus, activation of CXCR2 on ras-transformed keratinocytes has both promigratory and protumorigenic functions. The upregulation of CXCR2 ligands after initiation by oncogenic ras and promotion with TPA in the mouse skin model provides a mechanism to stimulate migration by both autocrine and paracrine pathways and contribute to tumor development.
Introduction
The essential contribution of inflammation to tumor development and progression has gained more attention based on clinical and experimental evidence. Accumulating data have ascribed both positive and negative influences of inflammatory pathways on tumor development and progression and have assigned these diverse influences to particular subsets of inflammatory cells, cancer stages, and target tissues (1) . Furthermore, controversy exists regarding the relative importance of interactions of tumorstromal inflammatory cells versus the role of soluble mediators released during those interactions (2, 3) . Many of these insights have been derived from studies of squamous cell tumor induction by 7,12-dimethylbenz(a)anthracene (DMBA) and 12-O-tetradecanoylphorbol-13-acetate (TPA) application on mouse skin. For example, mice deficient for tumor necrosis factor a or its receptors are resistant to chemically induced skin carcinogenesis (4, 5) , a result attributed to decreased inflammation in the dermis, notably neutrophil recruitment. Furthermore, skin resident ahT cells and gyT cells have opposite effects on the sensitivity to DMBA/TPA chemical skin carcinogenesis (6) . In the K14-HPV16 mouse skin cancer model, B lymphocytes recruit mast cells where they contribute to the angiogenic response of the stroma (7) . The facilitating role of neutrophils and macrophages on tumor angiogenesis has also been reported in a matrix inserted surface transplantation model using oncogene transformed HaCat cells (8) .
The recruitment of leukocytes is critically regulated by small cytokine-like soluble proteins called chemokines under both homeostatic and inflammatory conditions. Mouse neutrophils express a receptor homologous to human interleukin (IL)-8 (CXCL8) receptor or CXCR2. Mouse CXCR2 binds several CXCL-8 such as CXC chemokines most notably KC (CXCL1) and macrophage inflammatory protein 2 (MIP-2/CXCL2/3) and GCP-2 (CXCL6). KC and MIP-2 are related to the three human GRO chemokines (CXCL1/3). We and others have previously shown that transgenic mice that overexpress the conventional PKCa in basal keratinocytes exhibit an acute intraepidermal inflammatory response when mice were topically exposed to the PKC activator TPA (9, 10) . Driving the inducible cutaneous inflammation is a PKCa-dependent up-regulation of CXCR2 ligands attracting neutrophils into the epidermis, forming intraepidermal neutrophilic microabscesses, sloughing of the epidermis and a regenerative hyperplastic response emanating from the intact hair follicle epithelium (9, 11) .
This model system of inducible cutaneous inflammation offered an opportunity to address several questions related to tumor development. The relatively pure neutrophilic infiltration provided an opportunity to address the role of that cell type in the regenerative response. Epidermal regeneration from hair follicle cells tested the source of initiated cells. The dependence of the model on CXCR2-mediated responses provided a setting to question the function of this receptor and its ligands in tumor formation. The results indicate that CXCR2 and its ligands contribute to neoplastic development unexpectedly through an autocrine response loop that may prove a novel target for therapy.
Materials and Methods
Mice and treatments. Mouse studies were performed under a protocol approved by the National Cancer Institute (NCI) and NIH Animal Care and Use Committee. The construction and characterization of K5-PKCa mice on an FVB/N background were previously described (9) . K5-PKCa mice were crossed to homozygous mice deficient in CXCR2. F1 mice K5-PKCa/CXCR2 +/À were backcrossed to CXCR2 +/À to generate K5-PKCa mice deficient for CXCR2 (11) . TPA (Calbiochem) was dissolved in acetone, and 1 Ag was applied in 200 AL to the shaved dorsal skin of experimental animals.
Purified rat anti-mouse Ly-6G and Ly-6C (Gr-1, IgG 2b , n isotype) and purified rat IgG 2b , n isotype-matched control antibody were purchased from BD Biosciences. Mice were injected i.p. with 100 Ag of the anti-Gr1 antibody or isotype control 16 h before TPA application. Depletion of neutrophils reported earlier (12) was confirmed by differential white blood counts 12 h after TPA ( Supplementary Fig. S1A ), myeloperoxydase immunostaining of skin sections collected at 12 and 24 h after TPA ( Supplementary Fig. S1B ) and H&E staining of paraffin-embedded skin sections (data not shown). Approximately 1 h before sacrifice, animals were injected with 250 to 300 AL of a 3 mg/mL solution of BrdUrd in sterile PBS. Samples were fixed in formalin or IHC zinc fixative (BD Biosciences) and embedded in paraffin for H&E analysis and immunohistochemistry. For BrdUrd staining, sections were treated as recommended by manufacturer (Roche) using anti-bromodeoxyuridine-POD antibody (clone BMG 6H8). Apoptosis and CD31 staining were performed by the Pathology/Histotechnology Laboratory (NCI core facility) using, respectively, ApopTag kit (Millipore), anti-platelet/endothelial cell adhesion molecule 1/CD31 antibody (Santa Cruz; sc-1506) and antimyeloperoxidase (DAKO) on zincfixed sections. The microvascular density was determined by counting the number of CD31-stained cells in at least 5 fields (Â400 magnification; Nikon Eclipse E400) per tumor originating from CXCR2 wild-type (WT) or CXCR2 KO v-ras Ha -transduced keratinocytes. The antibodies against the mouse filaggrin and loricrin have been described previously (13) .
Tumor induction experiments. The backs of 7-wk-old mice were shaved 2 d before initiation with DMBA. Initiation was accomplished by a single topical application of 100 Ag DMBA in 0.2 mL acetone. Promoter treatments with TPA [1 Ag (1.6 nmoles) in 0.2 mL acetone, twice weekly] were begun 1 wk after initiation and continued for 20 wk. Skin tumors induced by the initiation-promotion protocol were removed and both frozen and formalin fixed at times from 20 to 52 wk after initiation. Tumor type [squamous papilloma or squamous cell carcinoma (SCC)] was verified by examination of H&E-stained sections of tumors.
Nude mouse grafting. On day 3 in culture, CXCR2 +/+ and CXCR2
À/À primary keratinocytes were infected with the v-ras Ha retrovirus, and trypsinized and used for grafting on day 8 as described previously (14) . Two million keratinocytes were mixed with 5 million SENCAR mouse dermal fibroblasts (cultured for 1 wk) and grafted onto the back of nude mice on a prepared skin graft site (14) . Tumor dimensions were measured weekly using calipers, and approximate tumor volumes were determined by multiplying tumor height Â length Â width.
Cell culture. Primary mouse keratinocytes and hair follicle buds were isolated from newborn transgenic and WT littermate epidermis as described (14) . Epidermal growth factor receptor (EGFR)-deficient keratinocytes were isolated from pups obtained from EGFR heterozygous breeding pairs (15) .
Retroviral and adenoviral constructs. The v-ras Ha replication defective ecotropic retrovirus was prepared using c2 producer cells (16) . Retrovirus titers were routinely 1 Â 10 7 virus/mL. Keratinocytes were infected with v-ras Ha retrovirus (oncogenic ras) on day 3 at a multiplicity of infection (MOI) of 1 in medium containing 4 Ag/mL Polybrene (Sigma). The mouse CXCR2 cDNA cloned into pEGFP-N1 vector (Clonetch) was a kind gift of Dr. Gao (Laboratory of Molecular Immunology, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD). The Entry clone for CXCR2-eGFP was transferred to the vector pAd/CMV/V5-DEST (Invitrogen) using Gateway LR recombination per the manufacturer's protocols. Adenoviral clones were verified by restriction analysis, and transfectionready DNA was made using the Sigma GenElute HP maxiprep kit in the Protein Expression Laboratory (Core Facility of NCI-Frederick). Adenoviruses were amplified in the Viral Technology Laboratory (Core Facility of NCI-Frederick). The InBaSR adenovirus was introduced into primary keratinocytes using an adenoviral construct driven by a cytomegalovirus (CMV) promoter and empty adenovirus was used as control (A-CMV). Adenoviruses were amplified using QBI 293 cells. Virus was purified over two CsCl gradients and dialyzed against a buffer containing Tris-HCl (pH 7.5), 10% glycerol, and 1 mmol/L MgCl 2 . Keratinocytes were infected for 30 min in serum-free medium with a MOI of 5 and 10 viral particles per cell (InBasr and CXCR2-EGFP, respectively) and 4.0 Ag/mL of Polybrene (Sigma) to enhance uptake. Serum containing medium was added to the cells for the next 16 or 48 h after the infection (CXCR2-EGFP and InBasr, respectively).
Immunoblotting. Cultured keratinocytes transduced with either control or mCXCR2-GFP adenovirus or an aliquot of cultured cells used for grafting experiments were lysed in MPER lysis buffer (Pierce) supplemented with 200 Amol/L NaVO 3 , 10 mmol/L NaF, and Complete Mini tablets (Roche). Proteins were quantified by the Bradford method (Bio-Rad) and separated by 10% or 18% SDS-PAGE for Akt/ERK or H-ras blotting, respectively. Akt and phospho-Akt antibodies (Cell Signaling) were used at 1:1,000 overnight, ERK and phospho-ERK antibodies (Cell Signaling) were used at 1:2,000 for 2 h at room temperature, and H-ras antibody (C-20; Santa Cruz Biotechnology) was used at 1:500 overnight at 4jC. ECL SuperSignal (Pierce) system was used for detection. The intensities of immunoblots were quantified using ImageJ (NIH), and the relative expression of targeted proteins was normalized.
In vitro migration assay. On day 3 in culture, CXCR2 +/+ and CXCR2
À/À primary keratinocytes were infected with the v-ras Ha retrovirus then used for migration assay on day 7. Keratinocytes were trypsinized and resuspended in ice-cold 0.2% serum culture medium. Cells (5 Â 10 5 ) were plated in the top chamber of noncoated polyethylene terephthalate membranes Biocoat control inserts (24-well plate insert with a pore size of 8.0 Am; BD Biosciences). MIP-2 (R&D systems) or transforming growth factor a (TGFa; R&D systems) were added to the bottom well in 0.2% serum culture medium at the concentration indicated. The CXCR2 smallmolecule antagonist was synthesized by Dr. Victor E. Marquez and Krishnan Malolanarasimhan (Laboratory of Medicinal Chemistry, NCI, Bethesda, MD) based on the structure previously reported (17) . CXCR2 antagonist was added concomitantly to the cells in the top chamber. The cells were incubated for 24 h, and those that did not migrate through the pores in the membrane were removed by scraping the membrane with a cotton swab. Cells on the underside of the membrane were stained with Diff-Quick (Dade Behring). Cells migrating across the filters were counted under light microscopy after coding the samples. The results were expressed as chemotaxis index, which represents the fold increase in the number of migrated cells in three Â40 fields in response to MIP-2 or TGFa over the spontaneous cell migration in response to control medium.
Time-lapse-microscopy studies. Keratinocytes were seeded on 12-well plates. On day 3 in culture, CXCR2 +/+ and CXCR2 À/À primary keratinocytes were infected with the v-ras Ha retrovirus then used for imaging on day 7 as described previously (18) . Briefly, imaging was performed on an Olympus IX81 research microscope (Olympus America), equipped with a Proscan motorized stage (Prior Scientific Instruments Ltd.), and placed in a temperature-and CO 2 -controlled chamber (LiveCell Incubation System; Neue Biosciences). Using relief-contrast optics, Â10 images were taken of each well every 10 min until 100 images were captured. For each variable, triplicate wells were tracked and images managed using . Cells were fixed using methanol and acetic acid (in a 3:1 ratio), solubilized in 5 N NaOH, and incorporated counts measured using a scintillation counter.
Transfection and luciferase reporter. The nuclear factor-nB (NF-nB)-luciferase plasmid DNA was a gift from Dr. Zheng-Gang Liu (NCI, NIH, Bethesda, MD). Primary keratinocytes were transfected using Lipofectamine 2000 according to the manufacturer's protocol (Invitrogen). Three days after ras transduction, transient transfection was carried out for an additional 48 h. Cells were then rinsed twice in PBS and harvested in reporter lysis buffer (BD Biosciences Clontech). Luciferase activity was measured by using the luciferase reporter assay kit (BD Biosciences Clontech) according to the manufacturer's protocol. Results were normalized to the total protein content.
Reverse transcription-PCR analysis. RNA was isolated from cultured cells with Trizol after manufacturer's protocol (Invitrogen). cDNA synthesis and real-time PCR analysis was previously described (11) . The primer sequences were as follows:
Predesigned Quantitect primers (Qiagen) were used for KC (CXCL1) and MIP-2 (CXCL2/3).
ELISA. KC and MIP-2 levels were quantified from culture supernatants using Quantikine ELISA kit according to the manufacturer's protocol (R&D Systems).
Statistical analysis. Data were analyzed by prism software, and significance values were assigned through Student's t test or One-Way ANOVA with Tukey posttest. P values of <0.05 was considered to be significant.
Results
PKCA overexpression in basal keratinocytes and hair follicles sensitizes mice to skin carcinogenesis. Application of TPA to the skin of K5-PKCa mice causes a neutrophilic infiltrate into the epidermis (9, 11). K5-PKCa mice and their WT littermates (WT) were compared for susceptibility to 100 Ag DMBA initiation followed by 1 Ag (1.6 nmoles) TPA twice weekly for 20 weeks of promotion. By week 21, 58% of the K5-PKCa mice developed tumors (with an average tumor multiplicity of 4.6 tumors per tumor-bearing animal), whereas all WT mice were tumor-free (Table 1A ; Fig. 1A) . None of the mice in control groups (initiation or promotion only) developed tumors. Sixty eight percent of papillomas converted to carcinomas by week 50 (Table 1A) reflecting the genetic predisposition for malignant skin tumor development on an FVB/N background (19) . Previous studies have indicated that mice overexpressing PKCa in the epidermis on a C57/Bl6 background (10) or FVB/N background (20) are not more susceptible to tumor induction than their WT counterpart. Although those results seem contradictory with the one we are currently reporting, they can be explained by the TPA regimen used for promotion. We have use a much lower dose (1.6 nmoles TPA twice a week), whereas the study on FVB/N mice used 5 nmoles TPA twice a week (20) and 3 nmoles TPA thrice a week for the (10) , conditions that were favorable for tumor development in WT mice. Our results show that PKCa overexpression in basal keratinocytes and potentially the consequent acute inflammation sensitize mice to skin carcinogenesis using a limiting DMBA initiation-TPA promotion protocol.
PKCA activation causes epidermal hyperplasia independently of acute neutrophil infiltration in the skin. Previous studies have shown that the intraepidermal neutrophilic infiltration after a single TPA treatment of K5-PKCa mice is followed by a prominent regenerative epidermal hyperplasia (9) . To test the contribution of neutrophils in the epidermal hyperplasia, K5-PKCa mice were depleted of their circulating neutrophils using Ly-6G antibodies. Ly-6G treatment of K5-PKCa mice prevented the systemic neutrophilia and the subsequent neutrophil infiltration and microabscess formation in the skin after TPA ( Supplementary  Fig. S1A and B) . After a single TPA application, epidermal hyperplasia and BrdUrd labeling in neutrophil depleted K5-PKCa mice and K5-PKCa mice receiving isotype control antibody were identical (Fig. 1B, C, and D) . Collectively, these results show that PKCa activation causes epidermal hyperplasia independently of acute infiltration by neutrophils.
Oncogenic ras up-regulates CXCR2 ligands in keratinocytes through activated PKCA and EGFR. The induction of the CXCR2 ligand CXCL8 by H-rasV12 in HeLa cells has been reported previously (21) . In the DMBA/TPA skin carcinogenesis model, virtually all tumors are initiated through mutational activation of H-ras raising the possibility that initiated cells could contribute to the chemokine milieu in the skin tumor microenvironment and thus to tumor formation. As seen in Fig. 2A , introduction of oncogenic ras into keratinocytes up-regulates mRNA expression of all three CXCR2 ligands (KC, MIP-2, and GCP-2). Keratinocytes also express the receptor CXCR2 itself, although oncogenic ras does not enhance the expression of the receptor CXCR2 mRNA (Fig. 2A) . Upregulation and secretion of these ligands by TPA has been shown to be mediated through PKCa and NF-nB (11, 22) . Oncogenic ras also increased the secretion of MIP-2 ( Fig. 2B ) and KC (data not shown) by keratinocytes. Blocking NF-nB transcriptional activity by introducing a dominant negative InB adenovirus reduced the v-ras mediated secretion of MIP-2 (Fig. 2B) . PKCa overexpression also enhanced oncogenic ras-mediated MIP-2 secretion, and this was also regulated by NF-nB. Blocking NF-nB did not affect CXCR2 mRNA expression (data not shown).
Previous studies have shown that oncogenic ras establishes an autocrine loop through the EGFR in murine keratinocytes by upregulating EGFR ligands (23) . To test whether EGFR autocrine signaling contributes to PKCa-mediated induction of CXCR2 ligands in v-ras transformed keratinocytes, we used keratinocytes from mice genetically ablated for the EGFR (15) . Disruption of autocrine EGFR signaling abolished the induction of MIP-2 and strongly reduced the induction of KC (Fig. 2C) . Collectively, these result suggest that ras-induced expression of CXCR2 ligands requires EGFR signaling and PKCa mediated activation of NF-nB.
CXCR2-deficient keratinocytes are defective in tumor formation. We have reported that the cutaneous inflammation in response to PKCa activation is ablated in the absence of CXCR2 (11) . The functional significance of CXCR2 expression by keratinocyte during skin carcinogenesis was tested by transducing primary keratinocytes from CXCR2 null mice with the v-ras Ha retrovirus and transplanting transduced tumorigenic cells to a prepared orthotopic graft site on nude mice that are otherwise CXCR2 intact. By this approach, tumor formation is dependent solely on the grafted keratinocyte CXCR2 as the host is competent for CXCR2 expression. As shown in Fig. 3A , tumor growth is retarded in the absence of keratinocyte CXCR2 relative to CXCR2 WT keratinocytes. Furthermore, tumor latency was greater and fewer mice hosting grafts lacking CXCR2 formed tumors than intact controls (Table 1B) . The expression of ras Ha was similar among the two keratinocyte genotypes as shown by Western blot from an aliquot of grafted cells (Fig. 3A, insert) . Proliferation in tumors arising from CXCR2-deficient v-ras keratinocytes was reduced by 31% when assayed by BrdUrd staining (Fig. 3B) . The number of apoptotic cells detected by terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling staining was similar in tumors originating from either genotype (Fig. 3C) . ELR + chemokines have been shown to have a direct proangiogenic activity on CXCR2 expressing endothelial cells. Because oncogenic ras induces CXCR2 ligand (MIP-2, KC, and GCP-2) expression similarly in primary keratinocytes from both genotypes (Supplementary Fig. S2 ) and CD31 staining of tumors from both groups show a similar vascular pattern (Fig. 3D) , and microvasculature density was the same among the two groups (Fig. 3D) , therefore, it is unlikely that the tumor growth difference was related to a defective paracrine angiogenic response by the host. Collectively, these results suggest that an autocrine/paracrine activation of keratinocyte CXCR2 contributes to the tumorigenic properties of Ras transformed keratinocytes.
CXCR2 deficiency impairs the migratory properties of transformed keratinocytes. The small size of tumors from v-ras Ha keratinocytes lacking CXCR2 strongly suggested a functional role for CXCR2 on keratinocytes and their transformed Figure 2 . Oncogenic H-ras up-regulates CXCR2 ligands in primary keratinocytes through EGFR, NF-nB, and PKCa. A, real-time PCR analysis of KC/CXCL1, MIP-2/CXCL2/3, GCP-2/CXCL6, and CXCR2 mRNA expression in control and v-ras Ha -transduced keratinocytes at indicated days after transduction. Bars, mean value of triplicate determinations. B, MIP-2 secreted into culture supernatant collected from control or v-ras transduced K5-PKCa or WT keratinocytes infected with A-CMV (control ) or degradation-resistant InBa (IjBaSR ) adenovirus to block NF-nB activity. Columns, mean SE of triplicate determinations; bars, SE. Results are representative of three independent experiments. *, P < 0.01 compared with respective nonras-transduced control; #, P < 0.05 compared with v-ras Ha WT keratinocytes A-CMV transduced. C, culture supernatants from EGFR WT or KO primary keratinocytes were collected after control or v-ras Ha transduction. KC and MIP-2 concentrations were determined by ELISA. Columns, mean of triplicate determinations; bars, SE.
derivatives. To further explore this issue, we used cultured genetically modified keratinocytes and recombinant CXCR2 ligands. Neither MIP-2 ( Supplementary Fig. S3A ) nor KC (data not shown) could stimulate 3 H-thymidine incorporation in cultured ras transformed keratinocytes. Similarly, cell proliferation was identical in CXCR2-deficient v-ras Ha -transformed keratinocytes and their WT counterpart ( Supplementary Fig. S3B ), suggesting that the reduction of proliferation observed in the tumors in vivo might be a secondary event to CXCR2 deficiency. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays revealed a similar TPA dose-dependent loss of cell viability in CXCR2-deficient v-ras Ha -transformed keratinocytes and their WT counterpart (Supplementary Fig. S3C ). Because activation of CXCR2 on hematopoietic cells results in a migratory response, we considered that the receptor on keratinocytes might have a similar function. Using Transwell inserts, we documented a chemotactic response of v-ras Ha -transformed WT keratinocytes toward a MIP-2 gradient and that response was absent in CXCR2-deficient v-ras keratinocytes (Fig. 4A) . Treatment of CXCR2 WT v-ras keratinocytes with a CXCR2 antagonist prevented their migratory response to MIP-2 (Fig. 4A) . In contrast, keratinocytes of both genotypes migrate similarly in response to TGFa (Fig. 4A) . Basal cell motility (measured by tracking cell movement) was identical in CXCR2 WT (0.42 F 0.07 Am/min.) and CXCR2-deficient v-ras keratinocytes (0.49 F 0.07 Am/min.). These observations suggest that the lack of chemotaxis in CXCR2-deficient v-ras keratinocytes was not due to defective cell motility. These data support a primary autocrine role for CXCR2 on the migration of transformed keratinocytes that in turn may be required for their tumorigenic outgrowth. CXCR2 deficiency has previously been shown to delay skin wound healing after excisional punch biopsy, owing to a migration defect of CXCR2-deficient keratinocytes (24) . A single low-dose TPA exposure on K5-PKCa skin causes sloughing of the epidermis followed by complete regeneration (9) . We tested whether migration secondary to CXCR2 expression would contribute to the epidermal regenerative response. In crosses of K5-PKCa/ CXCR2 KO mice, the skin is normal (Fig. 4B, Day 0) . Two days after TPA treatment, a nascent regenerative hyperplasia is observed in K5-PKCa/CXCR2 WT mice and a well-organized stratification of the hyperplastic epidermis is evident at day 3. In contrast, regeneration and hyperplasia are delayed in K5-PKCa/CXCR2 KO mice, and the epidermis that forms is deficient in the late epidermal differentiation markers loricrin and filaggrin at day 3 ( Fig. 4C ) in contrast to mice expressing CXCR2. By day 5, both differentiation markers are properly expressed in K5-PKCa/CXCR2 KO mice and hyperplasia is maximal. This delay in regenerative hyperplasia and expression of differentiation markers likely reflects the importance of CXCR2 in regulating keratinocyte migration both in vitro and in vivo.
To further show that CXCR2 is directly involved in keratinocytes migration, CXCR2-deficient v-ras keratinocytes were transduced with an adenovirus encoding for mouse CXCR2. As shown on Fig. 5A , CXCR2 reconstitution restored the chemotactic response to MIP-2. The mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI3K) pathways are two major signal transduction pathways activated by CXCR2 in response to its ligands (25, 26) . We tested the ligand-induced phosphorylation of ERK and Akt as indicators of MAPK and PI3K pathways activation in ras transformed keratinocytes. As shown in Fig. 5B both MAPK and PI3K pathways are activated by MIP-2 when CXCR2 null rastransformed keratinocyte are reconstituted with CXCR2 but not in the absence of reconstitution. TGFa activated similarly those pathways in both CXCR2-deficient and CXCR2-reconstituted rastransformed keratinocytes. Whether those two pathways are ) were grafted onto nude mice as a reconstituted skin, and average tumor volume was calculated as described in Materials and Methods. Points, mean; bars, SE. *, P < 0.05 compared with CXCR2 WT for the same time point. Each group contains 10 to 12 mice and results are representative of 2 independent experiments. Only mice bearing tumors were included in this figure. Insert, H-ras expression in an aliquot of v-ras keratinocyte used for grafting. B, BrdUrd-labeled nuclei were counted in five to seven randomly selected regions. Columns, mean; bars, SE. *, P < 0.05 compared with CXCR2 WT. Each group contains seven to nine tumors, and graphed data are representative of two independent experiments. C, apoptotic cells were identified using the Apoptag kit, which stains nuclei containing nicked DNA. Positive nuclei were counted in five to seven randomly selected regions. Columns, mean; bars, SE. Each group contains seven to nine tumors, and graphed data are representative of two independent experiments. D, immunostaining for CD31 antigen outlining blood vessels within tumors originating from CXCR2 WT (WT) or CXCR2 KO (KO) v-ras 
Discussion
Cutaneous SCC is the second most common cancer in the United States after basal cell carcinoma. Activating mutations in ras genes are observed in human SCC (27) and in experimental cutaneous SCC induction in mice (28) , and in the absence of mutations, human SCCs frequently show increased Ras activity and MAPK activation (29) . Although many downstream effectors of active ras have been delineated, those most critical for cutaneous SCC development remain obscure. Our current study shows that CXCR2 ligands are transcriptional targets of oncogenic ras in primary keratinocytes. We further show that CXCR2 ligand induction by oncogenic ras requires intact NF-nB nuclear translocation, is potentiated by PKCa, and is mediated through the EGFR. These findings connect three essential pathways in experimental skin carcinogenesis.
The skin carcinogenesis model has been particularly useful for illuminating the contribution of immune/inflammatory components for tumor development (4, 5, 7, 30) . These studies have revealed often opposing influences on tumor growth, immune surveillance, and angiogenesis of both humoral and cellular factors that are present in the tumor microenvironment. They have also emphasized crosstalk between tumor cells and the stroma to create the proper microenvironment. Less focus has been directed at potential tumor-tumor autocrine consequences of factors in the microenvironment. The current studies suggest how potential autocrine interactions can influence tumor development. The development of K5-PKCa mice that exhibit cutaneous inflammation in response to TPA provided an inducible system for the recruitment of neutrophils to the skin that specifically depends on keratinocyte-derived CXCR2 ligands (9, 11) . TPA also causes epidermal desquamation on K5-PKCa mice that is independent of CXCR2 ligands (11) . We now show that K5-PKCa mice exhibit increased sensitivity to tumor formation in the two-stage skin carcinogenesis model. Because recovery from epidermal desquamation occurs through migration and proliferation of hair follicles keratinocytes, we conclude that the initiated cells in this model WT and KO keratinocytes was tested in Transwell assays as described in Materials and Methods. MIP-2 or TGFa (10 ng/mL) diluted in low-serum containing medium (0) was used as stimulus in the bottom chamber while cells were seeded in the top chamber in low-serum containing medium. The CXCR2 antagonist was added to the cell suspension before the seeding in the top well. Fold increase (chemotactic index) of keratinocyte migration in response to treatment was compared with basal migration in the absence of stimulus. Columns, mean of two triplicate determinations; bars, SE. *, P < 0.001; #, P < 0.0001 compared with untreated control; x , P < 0.001 compared with untreated respective control. B, delayed epidermal regeneration in K5-PKCa mice deficient for CXCR2 after a single topical application of TPA. Skin biopsies were collected at 2, 3, and 5 d after a single TPA application on K5-PKCa/CXCR2 WT and K5-PKCa/CXCR2 KO and H&E stained. Bar, 50 Am. C, immunohistochemistry for filaggrin and loricin was performed on similar biopsies as in B collected at day 3 and 5.
must reside in the hair follicle compartment (31, 32) . Our results also link CXCR2 on keratinocytes to tumor formation in vivo. Specifically, when CXCR2-deficient v-ras-transformed primary keratinocytes are grafted orthotopically to CXCR2 competent hosts, tumor growth is severely retarded.
CXCR2 is strongly expressed by leukocytes, but it is also present on endothelial cells and embryonic and adult keratinocytes (24, 33) . Our study also shows that secreted CXCR2 ligands from rastransformed keratinocytes could not only recruit immune cells into the tumor microenvironment but could also promote angiogenesis and act directly on neoplastic keratinocytes in an autocrine/ paracrine manner. It is also likely that transformed keratinocytes could respond to CXCR2 ligands produced by neutrophils and endothelial cells present in the stroma (34) . CXCR2 ligands are proangiogenic in xenografts (21) , grafted murine SCC cells (35) , and models of lung and pancreatic cancers (36) . However, retarded tumor growth in our grafts of CXCR2 null-transformed keratinocytes cannot be explained by defective angiogenesis. The CXCR2 null tumor cells express abundant CXCR2 ligands (resulting from intact NF-nB activity in those cells; see Supplementary Fig. S3E ), the host endothelial cells were CXCR2 competent, and blood vessel density was similar in tumors from CXCR2 null and intact keratinocytes.
What then are the consequences of ligand activation of keratinocyte CXCR2? BrdUrd labeling shows a modest reduction in the number of proliferative cells in tumors derived from CXCR2 null keratinocytes, but, in vitro, CXCR2 ligands did not stimulate keratinocyte proliferation nor did oncogenic ras have a differential effect on proliferation of the two genotypes. Our studies indicate that CXCR2 activation mediates the migration of transformed keratinocytes in vitro, and migration is delayed in CXCR2 null epidermis after TPA-imposed epidermal desquamation. This result is consistent with the slow migration seen in CXCR2 null epidermis during cutaneous wound repair (24) and could perhaps impede cell turnover in tumors. Keratinocyte migration in response to autocrine or paracrine CXCR2 activation could provide the initiated cells with an advantage particularly during the early steps of tumor development when forming a critical clone size is necessary to expand in the context of a tightly regulated epithelial compartment (37) . This assumption is consistent with the finding that CXCR2 deficiency did not alter the malignant conversion rate of grafted tumor cells, which occurs as a late event in tumor progression. Previously, CXCR2 ligands have been shown to enhance proliferation of human cancer cell lines (38, 39) , but in the transformation of lining epithelial cells, migration may be particularly important to expand the zone of early transformants (37) . Crosstalk between CXCR1/2 with EGFR has also been reported in human ovarian cancer cells (40) , and we considered that the smaller tumor size could be related to changes in EGFR responses. However, the migratory response (Fig. 4) and proliferative response (data not shown) to exogenous TGFa in both CXCR2 WT and KO keratinocytes were similar. MAPK activity was increased in response to TGFa in CXCR2-deficient and CXCR2 reconstituted transformed keratinocytes (Fig. 5) although MAPK was not activated in CXCR2-deficient cells by CXCR2 ligands. Our reconstitution studies show that activation of both MAPK and Akt are downstream of CXCR2 activation in transformed keratinocytes. These two pathways have been linked to CXCR2 mediated cell migration in several cell lines (25, 26) , but recent studies suggest the association is more complex and involves additional pathways (41) . Further studies will be required to understand how signaling through CXCR2 in transformed keratinocytes regulates migration and how this migratory pathway contributes to tumor formation.
In human keratinocytes, EGFR activation causes a strong upregulation of IL-8 (42, 43) . Similarly, oncogenic ras induces transcripts of the EGF ligand family (namely TGFa, betacellulin, amphiregulin, and HB-EGF) and therefore contributes to the establishment of an autocrine loop (23, 44, 45) . We have shown previously that papillomas expressing v-ras but deficient for EGFR are growth impaired, but the proliferative pool of cells is not reduced. Instead, the tumor cells show altered migration and premature differentiation (46) . Our current study reveals that autocrine stimulation of EGFR is necessary for oncogenic rasmediated induction of CXCR2 ligands. This result suggests that up-regulation of CXCR2 ligands cannot be directly compensated by the constitutively active viral ras protein, and autocrine-activated EGFR is an essential mediator of this pathway in keratinocytes. Figure 5 . Reconstitution of CXCR2 KO keratinocytes with CXCR2 restores chemotaxis and signaling after MIP-2 treatment. On the 4th day after v-ras transduction, CXCR2 null primary keratinocytes were transduced with an empty adenovirus (control Ad ) or CXCR2 expressing adenovirus (CXCR2 Ad) for an additional 24 h and assayed for their ability to migrate in response to MIP-2 using the Transwell assays (A ) as described in Fig. 4 or (B) stimulated with 200 ng/mL MIP-2 or 10 ng/mL TGFa for 5 min. Western blots were performed for total and phospho-ERK 1/2 (p-ERK1/2) and total and phospho-Akt (p-Akt) as described under Materials and Methods. Relative levels of phospho-Akt and phospho-ERK are indicated in each figure normalized to the PBS-treated cells. *, P < 0.05 compared with untreated control.
The K5-PKCa mouse model has proven useful for addressing other consequences of inflammation in skin tumor development. For example, it has been proposed that the inflammatory infiltrate contributes to the sustained hyperplasia associated with tumor promotion. However, neutrophil depletion in K5-PKCa mice using an anti-Gr-1 antibody had no overt consequence on skin hyperplasia after TPA application. Because an anti-Gr1-based approach allows only for a temporary depletion of neutrophil as it is followed by a rebound in granulocytes counts (47) , it therefore does not allow for the study of the contribution of neutrophils during a complete promotion stage. Interestingly, the pioneer work of the Schreiber' group showed that elimination of Gr-1 + leukocytes in athymic nude mice slowed the growth of a variant of a UV lightinduced tumor (48) . Activation of CXCR2 on Gr-1 +
CD11b
+ myeloid cells (also called myeloid-derived suppressor cells) was recently shown to mediate their recruitment to mammary carcinoma (49) . Gr1 + CD11b
+ cells can contribute to tumor immune evasion ( for review see ref. 50 ), angiogenesis, but also tumor invasion and metastasis (49) . Therefore blocking CXCR2 seems as an attractive target to prevent the recruitment of Gr-1 + leukocytes to the tumor site. That therapeutic approach would also benefit from the blockade of keratinocyte CXCR2 as our results suggest that it contributes important autocrine/paracrine function during skin carcinogenesis.
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